home / stock / cgen / cgen quote
Last: | $1.99 |
---|---|
Change Percent: | 0.0% |
Open: | $1.93 |
Close: | $1.99 |
High: | $2.05 |
Low: | $1.875 |
Volume: | 333,396 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.99 | $1.93 | $1.99 | $2.05 | $1.875 | 333,396 | 05-01-2024 |
$1.93 | $1.98 | $1.93 | $1.98 | $1.88 | 274,515 | 04-30-2024 |
$1.98 | $1.92 | $1.98 | $2 | $1.92 | 277,619 | 04-29-2024 |
$1.92 | $1.89 | $1.92 | $1.98 | $1.855 | 326,190 | 04-26-2024 |
$1.9 | $1.96 | $1.9 | $2.03 | $1.89 | 268,596 | 04-25-2024 |
$1.91 | $1.96 | $1.91 | $1.985 | $1.9 | 164,669 | 04-24-2024 |
$1.98 | $1.88 | $1.98 | $2.025 | $1.88 | 232,447 | 04-23-2024 |
$1.89 | $1.91 | $1.89 | $1.96 | $1.87 | 202,009 | 04-22-2024 |
$1.9 | $1.91 | $1.9 | $1.97 | $1.835 | 325,372 | 04-19-2024 |
$1.88 | $1.88 | $1.88 | $1.96 | $1.8301 | 308,855 | 04-18-2024 |
$1.9 | $2.03 | $1.9 | $2.04 | $1.9 | 372,625 | 04-17-2024 |
$2.03 | $1.96 | $2.03 | $2.05 | $1.9 | 451,682 | 04-16-2024 |
$1.96 | $2.11 | $1.96 | $2.19 | $1.94 | 752,822 | 04-15-2024 |
$2.13 | $2.23 | $2.13 | $2.25 | $2.09 | 388,383 | 04-12-2024 |
$2.26 | $2.26 | $2.26 | $2.27 | $2.2 | 244,801 | 04-11-2024 |
$2.26 | $2.31 | $2.26 | $2.33 | $2.23 | 279,682 | 04-10-2024 |
$2.36 | $2.34 | $2.36 | $2.4001 | $2.33 | 152,091 | 04-09-2024 |
$2.33 | $2.47 | $2.33 | $2.47 | $2.33 | 194,450 | 04-08-2024 |
$2.42 | $2.34 | $2.42 | $2.505 | $2.3114 | 366,017 | 04-05-2024 |
$2.32 | $2.38 | $2.32 | $2.47 | $2.32 | 322,750 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Compugen Ltd. Company Name:
CGEN Stock Symbol:
NASDAQ Market:
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024 PR Newswire HOLON, Israel , April 25, 2024 /PRNewswire/ -- Compugen Ltd...
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 PR Newswire HOLON, Israel , April 10, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pione...
Compugen to Participate in Two Upcoming Investor Conferences PR Newswire HOLON, Israel , April 3, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, tod...